Podoplanin
D2-40, Ms
Artikelnummer: | PO004-H_RUO |
Technische Daten
Change(s) made: | Complete revision | Status: | Research Use Only (RUO) | Spezies: | Mouse | Ig Unterklasse: | IgG | Immunogen: | Podoplanin | Vorbehandlung: | ProTaqs® Antigen Enhancer I (Cat. No. 401602092) or ProTaqs® Antigen Enhancer IV (Cat. No. 401602392) | Zelluläre Lokalisation: | Cytoplasmic | Kontrolle: | Lymph node, tonsil | Synonyme: | AGGRUS, GLYCOPROTEIN 36 KD, Podoplanin, Glycoprotein 36, gp 36, GP 38, GP 40, gp36, GP38, GP40, HT1A 1, HT1A1, hT1alpha1, hT1alpha2, Lung type I cell membrane associated glycoprotein, Lung type I cell membrane associated glycoprotein isoform a, Lung type I cell membrane associated glycoprotein T1A 2, OTS 8, OTS8, OTTHUMP00000009640, OTTHUMP00000044504, PA2.26, PA2.26 antigen, PDPN, Podoplanin, T1 alpha, T1 ALPHA GENE, T1A, TIA 2, TIA2. | Verfügbar in folgenden Ländern: | worldwide |
Beschreibung
Podoplanin is a type-I integral membrane glycoprotein that is selectively expressed in lymphatic endothelium. The exact molecular function of podoplanin in the lymphatic endothelium has remained unclear. This antibody detects lymphangiomas, Kaposi sarcomas and a subset of angiosarcomas with probable lymphatic differentiation
|